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The highly conserved COP9 signalosome (CSN)
complex is a key regulator of all cullin-RING-ubiquitin
ligases (CRLs), the largest family of E3 ubiquitin li-
gases. Until now, it was accepted that the CSN is
composed of eight canonical components. Here,
we report the discovery of an additional integral
and stoichiometric subunit that had thus far evaded
detection, and we named it CSNAP (CSN acidic pro-
tein). We show that CSNAP binds CSN3, CSN5, and
CSN6, and its incorporation into the CSN complex
is mediated through the C-terminal region involving
conserved aromatic residues. Moreover, depletion
of this small protein leads to reduced proliferation
and a flattened and enlarged morphology. Finally,
on the basis of sequence and structural properties
shared by both CSNAP and DSS1, a component of
the related 19S lid proteasome complex, we propose
that CSNAP, the ninth CSN subunit, is the missing
paralogous subunit of DSS1.INTRODUCTION
The COP9 signalosome (CSN) complex is an evolutionarily
conserved protein complex that exists in all eukaryotes (for
reviews, see Schwechheimer, 2004; Wei et al., 2008). It con-
tains eight canonical subunits that are termed CSN1 through
CSN8, according to the descending order of molecular weights.
The complex was originally identified as an essential factor
that regulates light-induced development in Arabidopsis thaliana
(Chamovitz et al., 1996; Wei et al., 1994); since then, it has
been shown to play a critical role in diverse cellular processes
including early development, DNA repair, cytokine signaling,
regulation of nuclear transport, cell-cycle progression, angio-
genesis, and antigen-induced responses (Schwechheimer,
2004; Wei et al., 2008). The involvement of the CSN in multiple
cellular pathways is tied to its biochemical function as a regulator
of the ubiquitin proteasome degradation pathway (Adler et al.,C2006). Specifically, CSN coordinates the activity of cullin-RING
ligases (CRLs) (Adler et al., 2006; Deshaies and Joazeiro, 2009).
The CRLs are a family of ubiquitin E3 enzymes that conjugate
ubiquitin onto target proteins, thereby exerting a huge impact on
cellular regulation (Deshaies and Joazeiro, 2009). Ubiquitination
frequently leads to degradation of the target protein; indeed,
20% of proteasome-dependent degradation is mediated by
CRL ubiquitination (Soucy et al., 2009). Yet, in some cases,
CRL-dependent ubiquitination acts as a switch to activate,
repress, or relocalize target proteins. The CSN deactivates
CRL function in two ways: (1) by deconjugation of the ubiqui-
tin-like protein Nedd8 from the cullin subunit (deneddylation),
an enzymatic process carried out by CSN5 (Cope et al., 2002);
or (2) by physically binding to deneddylated CRLs, precluding
interactions with E2 enzymes and ubiquitination substrates
(Emberley et al., 2012; Enchev et al., 2012; Fischer et al.,
2011). In mammals, the CRL family comprises eight cullin mem-
bers (Cul1–Cul7 and PARC) and hundreds of substrate receptor
modules that enable specific ubiquitination of multiple proteins
involved in diverse cellular processes (Lydeard et al., 2013).
Thus, vigorous control of CRLs by the CSN is critical for an or-
ganism’s normal development and survival. It is therefore not
surprising that impairment of CSN function is linked with multiple
cancers (reviewed in Lee et al., 2011; Richardson and Zundel,
2005; Zhang et al., 2013).
The recently determined crystal structure of the recombinant
CSN (Lingaraju et al., 2014) exposed the dynamic and fairly
extended conformation of this complex. In particular, its archi-
tecture is governed by two organizational centers (Lingaraju
et al., 2014): an open horseshoe-shaped structure formed by
the ‘‘winged helix’’ subdomains of the six PCI subunits (protea-
some, COP9, and initiation factor 3) (Hofmann and Bucher,
1998), CSN1–CSN4, CSN7, and CSN8, and an elaborate bundle
comprising the carboxy-terminal ends of each subunit. Sitting
atop this platform is the heterodimer formed by the MPN
(Mpr1p and Pad1pN terminal) (Aravind and Ponting, 1998; Glick-
man et al., 1998; Hofmann and Bucher, 1998) subunits, CSN5
andCSN6. Binding of neddylated CRLs toCSN triggers substan-
tial remodeling of the complex, activating the isopeptidase activ-
ity of CSN5. Given that the CSN is a key regulator of all CRLs, a
high degree of flexibility is essential to facilitates its binding toell Reports 13, 585–598, October 20, 2015 ª2015 The Authors 585
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this structurally diverse family of more than 200 distinct com-
plexes, including higher-order structures (Errington et al., 2012;
Zhuang et al., 2009).
Notably, the CSN complex shares sequence similarities with
two multi-subunit protein complexes: the lid component of the
19S proteasome and the eukaryotic translation initiation factor
3 (eIF3) (Glickman et al., 1998; Scheel and Hofmann, 2005;
Seeger et al., 1998). While the eIF3 complex is more distinct
and contains a larger number of subunits, the lid and the CSN
exhibit a remarkable one-to-one correspondence between their
two MPN and six PCI subunits. Beside this sequence homology,
recent studies revealed that the two complexes also display
similar architectures (da Fonseca et al., 2012; Enchev et al.,
2012; Lander et al., 2012; Lasker et al., 2012; Lingaraju et al.,
2014; Rockel et al., 2014). However, the 19S lid complex con-
tains an additional small, non-PCI or MPN subunit, known as
DSS1 (Sem1 in yeast), that has not yet been identified in the
CSN assembly (Sone et al., 2004).
Here, we provide several lines of evidence indicating that a
small, intrinsically disordered protein, which we named CSNAP
(CSN acidic protein; previously named MYEOV2), is an integral
subunit of the CSN complex. Our findings support results indi-
cating that CSNAP is pulled down together with CSN subunits
(Dunhamet al., 2011; Ebina et al., 2013; Sowa et al., 2009). More-
over, we demonstrate that CSNAP, which is present at unit stoi-
chiometry, tethers together the two distinct structural elements
of the complex by mutually binding the MPN subunits, CSN5
and CSN6, and the PCI subunit CSN3. Furthermore, the C-termi-
nal end of CSNAP, which is enriched with phenylalanine and
aspartic acid residues, is crucial for its integration into the
CSN. The lack of CSNAP yields a cellular phenotype character-
ized by reduced cell proliferation and a flattened and enlarged
morphology. Finally, we suggest that CSNAP is the missing ho-
mologous subunit of DSS1, the only 19S lid subunit missing a
counterpart in the CSN.
RESULTS
The CSN Complex Associates with CSNAP
Once the endogenous CSN complex was isolated from human
erythrocytes, we examined its composition using a liquid chro-
matography mass spectrometry (LC-MS)-based approach that
we recently developed (Rozen et al., 2013). This method, which
couples bottom-up and top-down MS analysis, enables charac-
terizing the protein complexes’ subunit composition. Initially, theFigure 1. CSNAP Physically Associates with the CSN Complex
(A–C) The endogenous CSN complex isolated from human erythrocytes (A and
monolithic column under denaturing conditions. A colored frame highlights the
persistently detected alongside the eluted CSN subunits, implying its associatio
(B) The resulting electrospray ionization quadrupole time-of-flight mass spectra a
protein and its associated variants; proteomics analysis was performed for sequ
gesting that it associates with the complex. Indicated masses are an average of
labeling with circles and squares.
(D) Nano-electrospray mass spectrum recorded under native conditions of the h
observed between 8,500 and 10,500 m/z. The 36+ and 35+ charge states (inset)
(E) MS/MS spectrum showing the individual subunits stripped from the CSN com
assign peaks corresponding in mass to CSNAP, indicating that it interacts with t
Cconstituent subunits are separated on a column under dena-
turing conditions. Following subunit elution from the column,
the flow is split into two fractions. One fraction is directed straight
into the mass spectrometer for intact protein mass measure-
ments, while the rest of the flow is fractionated into a 96-well
plate, for subsequent peptide sequencing and subunit identifica-
tion. The heterogeneity of subunit composition is then deter-
mined by correlating the subunit mass with its sequence identity.
By applying the LC-MS approach, all eight subunits of theCSN
complex could be separated, including the two isoforms of
CSN7 (Figure 1; Table S1). Data analysis demonstrated that all
CSN subunits except for CSN1, CSN2, and CSN8 lack the first
methionine (Met) residue and carry an N-terminal acetylation.
In addition, the molecular mass of CSN2 suggests that the pro-
tein is a product of an alternative translation site at Met9. Simi-
larly, two alternatively translated forms of CSN8 were identified:
themass of the heavier CSN8 variant corresponds to the removal
of the first methionine, and the lighter form is a product of an
alternative translation initiation site at Met6. The relative intensity
of the two forms indicated that only 30% of the CSN8 inte-
grated within the CSN complex corresponds to the shorter
form of the subunit, while the majority of CSN8 corresponds to
the full-length protein.
Beyond the inherent diversity of CSN subunits, we noted the
repetitive co-elution (retention time: 8 min) of an additional
component, along with CSN subunits (Figures 1A and 1B). Ac-
cording to online MS measurements, we determined that this
is a small protein, with a molecular weight of 6.2 kDa. Proteomic
analysis identified the protein asmyeloma overexpressed gene 2
(MYEOV2), which from now on we refer to as CSNAP, for CSN
acidic protein. As will become apparent, CSNAP is the ninth sub-
unit of the CSN complex. Though this subunit could have been
named CSN9, this already designates the CSN7-like subunit of
Saccharomyces cerevisiae (Maytal-Kivity et al., 2003).
To determine whether CSNAP specifically interacts with the
CSN complex, rather than being a contaminate protein, we puri-
fied the complex from a different source: HEK293T cells stably
expressing a FLAG-tagged CSN2 subunit. Because entirely
different purification strategies were applied to isolate the CSN
complex in each system (multi-column biochemical purification
for erythrocytes and a single-step FLAG protocol for HEK293T
cells) and there are great differences between these two cell
types, it is unlikely that a similar contaminant protein would co-
elute with the CSN in both systems. The subunit elution profile
of the CSN complex isolated from HEK293T cells was veryB) and HEK293 cells (C) was separated into its component subunits, using a
retention time of each eluted protein (A and C). CSNAP (labeled as C) was
n with the CSN complex.
re shown. These spectra made it possible to determine the mass of the eluted
ence identification. CSNAP repeatedly co-eluted with the CSN subunits, sug-
biological and technical measurements. Subunit variants are differentiated by
uman CSN complex isolated from HEK293T cells. The intact CSN complex is
were selected for MS/MS analysis.
plex. In addition to the dissociation of CSN6, CSN7b, and CSN8, we could also
he CSN complex. The different species are denoted with labeled circles.
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Figure 2. The Short Isoform of the MYEOV2 Gene, CSNAP, Interacts with the CSN Complex
(A) Schematic representation of the two alternatively spliced products of the MYEOV2 gene. Amino acid residues colored in red represent the CSNAP sequence
(57 amino acids). The long MYEOV2 protein (252 amino acids, My2-L) contains the entire sequence of the short transcript except for glutamine 57, as well as
additional sequence stretches in internal and end regions (shown in black).
(B) Native PAGE separation (6%) of the purified CSN complex. The position of the complex is denoted by an arrow; the absence of additional bands in the gel
indicates the high integrity of the complex. Proteins extracted from the labeled band were subjected to proteomic LC-MS/MS analysis. Identified proteins with
sequence coverageR30% are listed.
(legend continued on next page)
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similar to that obtained for the CSN isolated from erythrocytes
(Figure 1C).
Apart from the CSN subunits, we identified additional proteins
common to both erythrocytes and HEK293 cells that were
co-purified with the CSN (Table S2). These include expected
members of the ubiquitin-proteasome system, the proteasome
inhibitor PI31, SKP1, a member of the SCF (Skp1-cullin-F-box
protein) complex, as well as chaperones and cytoskeleton-
related proteins. Included among these proteins was also
CSNAP (Figure 1C), suggesting that it is not a contaminant pro-
tein but rather a specific binding partner of the CSN complex.
CSNAP Physically Binds the CSN Complex
To determine whether CSNAP physically interacts with the CSN
complex, we applied the native MS approach under conditions
that maintain non-covalent interactions between protein sub-
units (Sharon, 2013). In this experiment, the intact CSN complex
appeared as a charge state series at 9,500 m/z (Figure 1D).
However, due to the diversity of CSN subunits (Table S1) and
CSNAP’s small size, it was impossible to determine unambigu-
ously whether it binds to the CSN. Therefore, tandem MS (MS/
MS) experiments were performed, in which a single peak corre-
sponding to CSN ions was isolated. The ions were then sub-
jected to collisional activation, and the individual subunits
stripped from the complex were identified (Sharon, 2013). This
process yielded not only the dissociation of canonical CSN sub-
units as CSN8, CSN7b and CSN6 but also the ejection of CSNAP
(Figure 1E). By extrapolation, we can conclude that prior to the
MS/MS analysis, CSNAP was bound to the CSN complex.
The Short Isoform of CSNAP Is a Component of the CSN
Complex
The MYEOV2 gene comprises two alternatively spliced isoforms
(Figure 2A). The first encodes a protein containing 57 amino
acids (molecular weight: 6.2 kDa), which we termed CSNAP.
The second transcript generates a 252-amino-acid-long protein,
with a calculated molecular weight of 27.7 kDa, known as
MYEOV2-L. Even though the sequence of the shorter variant,
CSNAP, is embedded within MYEOV2-L, we can unambiguously
distinguish between the two proteins via proteomic analysis.
This is becauseMYEOV2-L contains a short sequential insert be-
tween residues 43 and 52, and CSNAP includes a unique C-ter-(C) HEK293T FLAG-CSN2 cell extract was subjected to Superdex 200 gel-filtratio
immunoblotting. CSNAP co-fractionated with theCSNcomplex, unlikeMYEOV2-L
weights are indicated in kDa units. All experiments were repeated at least three
(D) Whole-cell lysates (L) from HEK293T (HEK) cells stably expressing FLAG-CSN
lysates from HeLa cells transiently expressing CSNAP-FLAG (right panel), were su
antibody (IP-3). Pull-downswere analyzed by western blots using antibodies again
long version of MYEOV2, co-immunoprecipitates with the CSN complex. As con
interactions, lysates were also incubated with Protein G Sepharose, without the
(E) CSN was co-immunoprecipitated from HEK293 stably expressing FLAG-CSN
bound (IP) and unbound (UB) fractions were analyzed by western blots using ant
controls. The depletion of CSN2 and CSNAP from the unbound fraction suggests
this small protein is not part of another protein complex.
(F) CSN was subjected to targeted proteomic analysis by selective reaction m
standards. Absolute quantification was done by referencing the native peptide
representative peptide. Results indicate that CSN subunits and CSNAP are presen
with two technical replicates each. Error bars indicate the SDs of all six measure
Cminal glutamine residue (Gln57). Considering that our LC-MS
analysis (Figure 1) involved both molecular weight measure-
ments and proteomic analysis, we could clearly demonstrate
that CSNAP is the variant associated with the CSN. Neverthe-
less, we wished to determine whether MYEOV2-L could also
interact with the complex.
We began by separating the endogenous CSN complex on a
6% native PAGE (Figure 2B). Only a single band was detected
in the gel, indicating not only the high purity of the sample but
also the stability of the complex. We then extracted the proteins
from the band and performed a proteomic LC-MS/MS analysis
using a 30% sequence identity coverage cutoff. Together with
the eight canonical CSN subunits, CSNAP, but not MYEOV2-L,
was also identified (Figure 2B, right panel), suggesting that unlike
CSNAP, MYEOV2-L is not a component of the CSN complex.
To further strengthen our results, we generated a polyclonal
antibody against a synthetic peptide containing the entire
CSNAP sequence, which recognized both the CSNAP and
MYEOV2-L isoforms. We then performed a gel filtration analysis
of HEK293 cell extract to monitor whether these proteins co-
elute with the CSN complex. Western blot analysis indicated
that CSNAP displays an elution profile similar to those of
CSN1, CSN3, and CSN8, while MYEOV2-L elutes at lower-mo-
lecular-weight fractions (Figure 2C), supporting our premise
that MYEOV2-L is not part of the CSN complex.
Next, reciprocal co-immunoprecipitation experiments were
performedusingbothHeLa andHEK293 cell extracts (Figure 2D).
The results obtained for the two cell lines were virtually the same:
When cells transiently expressing CSNAP-myc-FLAG were co-
immunoprecipitated using an anti-FLAG resin, CSN1, CSN3,
CSN5, and CSN8 were pulled down. When anti-CSN3 was
used for pull-down in HeLa cells, the antibody directed toward
CSNAP gave rise to two bands: an intense band at CSNAP’s
molecular weight and a second, faint band corresponding in
size to MYEOV2-L. Notably, the intensity of the MYEOV2-L
band was similar to the nonspecific signal that appeared when
non-conjugated beads were used as a negative control, sug-
gesting that this faint band is a product of a nonspecific interac-
tion. When we used HEK293T cells stably expressing FLAG-
CSN2 and an anti-FLAG resin, CSNAP, but not MYEOV2-L,
was pulled down. Similar results were also obtained when
reciprocal co-immunoprecipitation experiments were performedn chromatography. Fractions were collected and analyzed by SDS-PAGE and
, that eluted in lower-molecular-weight fractions. In all western blots, molecular
times.
2, or HEK293 cells transiently expressing CSNAP-FLAG (left panel), as well as
bjected to immunoprecipitation (IP) using FLAG affinity gel (IP-F) or anti-CSN3
st CSN subunits, CSNAP, and FLAG. The results show that CSNAP, but not the
trols, wild-type HEK293 and HeLa lysates were used. To rule out non-specific
addition of the primary antibodies (NS).
2, using an anti-CSN3 antibody or anti-FLAG resin. The whole-cell lysates (L)
ibodies against CSNAP and FLAG. GAPDH and My2-L were used as negative
not only that the majority of CSN complexes are bound to CSNAP but also that
onitoring (SRM) mass spectrometry and stable, isotopically labeled peptide
intensities to the heavy labeled standards and then normalizing against a
t in equimolar amounts. Data shown are the result of three biological replicates,
ments.
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using A31N-ts20 BALB/c mouse embryo fibroblast cells (Fig-
ure S1). Moreover, pull-down assays using anti-FLAG resin or
an anti-CSN3 antibody depleted both CSNAP and FLAG-CSN2
from the unbound fraction, unlikeMYEOV2-L or GAPDH, respec-
tively (Figure 2E). This result suggests that cellular CSNAP is pre-
sent in themajority of CSN complexes. Altogether, the data imply
that only CSNAP, and not MYEOV2-L, is a bona fide member of
the CSN complex.
CSNAP Is a Stoichiometric Subunit of the CSN Complex
To determine whether CSNAP is a stoichiometric component
of the CSN, we subjected the anti-CSN3 immunoprecipitated
complex to targeted proteomic analysis by selective reaction
monitoring (SRM) MS for absolute quantification (based on
the AQUA approach) (Me´ne´tret et al., 2007). Custom stable-
isotope-labeled peptides of CSN2, CSN4, and CSNAP were
synthesized and quantified by amino acid analysis. Those were
spiked into the complex samples, enabling absolute quantifica-
tion of the CSN and CSNAP subunits by converting light/heavy
peak area ratios into absolute protein amounts. Values were
then normalized against a representative peptide (Figure 2F).
We found that the measured stoichiometry of CSN2, CSN4,
and CSNAP was 1:1:1, indicating that CSNAP, like the other
CSN subunits, is present in equimolar amounts.
The C-Terminal F/D-Rich Region of CSNAP Mediates Its
Association with CSN, with Phe44 and Phe51 Playing
Direct Roles in the Interaction
To clarify which domain within CSNAP mediates its interaction
with the CSN complex, we transiently expressed several ver-
sions of CSNAP, including deletion mutants of either the N- or
C-terminal regions, fused to the fluorescent protein Cerulean
(Cer) in HEK293 cells (Figure 3A). Initially we examined the
cellular localization of CSNAP. Full-length CSNAP constructs
were seen throughout the cytoplasm and nucleus but were
excluded from nucleoli (Figure S2), as previously observed for
other CSN subunits (F€uzesi-Levi et al., 2014).We then performed
reciprocal co-immunoprecipitation analyses, using antibodies
against CSN3 and GFP (Figure 3B). The results indicated that
fusing Cer to either terminus of CSNAP did not hinder its ability
to interact with CSN. Likewise, deletion of the N-terminal region
of CSNAP did not affect the CSNAP/CSN association. However,
CSNAPwas unable to bind CSN in the absence of the C-terminal
fragment, suggesting that this region is essential for interaction
with the complex.
Analysis of the amino acid sequence of CSNAP indicates
that it is enriched with charged and polar amino acids, charac-
teristic of intrinsically disordered proteins (Dyson and Wright,
2005). Such proteins, however, tend to adopt distinct struc-
tures in their bound state. When we examined CSNAP’s C-ter-
minal sequence, the region critical for its incorporation into the
CSN, we noticed not only that it is rich in phenylalanine and
aspartic residues (F/D-rich domain) but also that the two types
of residues are alternately spaced three and four residues
apart. This observation suggests that this C-terminal region
might adopt a binding configuration of an amphipathic a-helix
containing both aromatic and negatively charged sides (Fig-
ure 3C). It is therefore reasonable to assume that the aromatic590 Cell Reports 13, 585–598, October 20, 2015 ª2015 The Authorsface is buried within the complex forming the CSNAP/CSN
interface.
To test this hypothesis, single and double mutants were intro-
duced into DN-CSNAP-Cer at positions 44 and 51 (F44A, F51A,
F44A-F51A). The mutant proteins were transiently expressed in
HEK293 cells, and subjected to reciprocal co-immunoprecipita-
tion with antibodies against CSN3 and GFP (Figure 3D). Though
the F44A mutation did not interfere with the CSNAP/CSN inter-
action, and binding of the F51A CSNAP mutational variant to
CSN was noticeably reduced, it was the F44A-F51A double
mutant that displayed the most striking phenotype, completely
abolishing the ability of CSNAP to interact with the CSN. There-
fore, within the F/D-rich C-terminal region of CSNAP, F44 and
F51 are necessary mediators of its interaction with the CSN.
Cellular Analyses Indicate that CSNAP Is an Integral
Subunit of the CSN Complex
We recently demonstrated that following induction of UV dam-
age, the CSN complex is transiently recruited to the nucleo-
plasmic and chromatin fractions (F€uzesi-Levi et al., 2014). We
therefore wished to explore whether CSNAP acts as an integral
CSN component and displays a similar relocalization pattern.
To this end, HeLa cells were exposed to UV irradiation, and cells
were then fractionated (Figure 4A). Our findings indicated that
the level of cytosolic CSNAP did not significantly change in
response to UV irradiation, though a clear increase in CSNAP in-
tensity was observed in the nucleoplasmic and chromatin-asso-
ciated fractions immediately after UV irradiation, as observed for
CSN subunits. However, no change in the intensity levels of
MYEOV2-L was detected. This finding confirms the analogous
cellular response of CSNAP and the CSN complex.
To study the diffusion kinetics of CSNAP in live cells, we per-
formed fluorescence recovery after photobleaching (FRAP) mea-
surements in both the cytosol and nuclear compartments of
HEK293 cells stably expressing different fluorescently tagged
CSNAP constructs (Luijsterburg et al., 2007). Previously, we had
demonstrated that the recovery curves of CSN2, CSN3, CSN6,
andCSN7subunits areverysimilar, indicating that theycommonly
reside within the holo-CSN complex (F€uzesi-Levi et al., 2014).
Thus, if CSNAP is an integral subunit of the complex, it is expected
to display comparable mobility. For comparison, we conducted
similar measurements on cells stably expressing free Cer and
Cer-CSN3, representing the dynamics of a fully mobile, mono-
meric protein (Dross et al., 2009) and the CSN complex, respec-
tively. As an additional control, we used cells stably expressing
fluorescently tagged DDB2, a nuclear DNA-binding protein previ-
ously shown to interact with the CSN, though not an integral sub-
unit of the complex (Groisman et al., 2003; Olma et al., 2009).
Examination of the resulting data indicated that Cer-CSNAP
and Cer-CSN3 recovery curves were remarkably similar, dis-
playing significantly slower mobility compared to that of free
Cer, and suggesting that Cer-CSNAP is part of the CSN complex
(Figures 4B and S3). In contrast, the mobility kinetics of the
CSNAP construct lacking the C-terminal F/D region were com-
parable to that of free Cer, further demonstrating that this region
is critical to CSNAP incorporation into the CSN. The absence of
the N-terminal region did not affect the recovery rate, which was
similar to that of Cer-CSNAP and Cer-CSN3, suggesting that the
Figure 3. The F/D-Rich C-Terminal Domain of CSNAP, Specifically Phe44 and Phe51, Is Involved in Its Interaction with the CSN Complex
(A) Schematic representation of the different CSNAP constructs used in this experiment.
(B) Cellular proteins extracted from the different fluorescently tagged HEK293 cell lines were immunoprecipitated, using anti-GFP and anti-CSN3 antibodies. As
control, lysate from HEK293 cells stably expressing FLAG-CSN2 was used. Lysates (L) were run side by side with their corresponding immunoprecipitated
proteins (IP) and visualized using various antibodies, as indicated (IB). Results show that CSNAP-DC-Cer did not interact with the CSN, indicating that the
C-terminal domain is responsible for its interaction with the complex.
(C) Helical wheel representation of the CSNAP C-terminal region. Hydrophilic and hydrophobic residues are colored blue and green, respectively. Distribution of
the residues on either side of the helix suggests amphipathic properties for this structure.
(D) Lysates (L) from HEK293 cells expressing DN-CSNAP-Cer (WT) and its mutational variants, consisting of single (F44A and F51A) and double (F44A-F51A)
amino acid substitutions, were immunoprecipitated by either anti-GFP or anti-CSN3 (IP). Pull-downs were analyzed by western blot, using antibodies against
GFP andCSN subunits. Findings show that while Phe44 displacement yielded results similar to those of theWT construct, the F51Amutant extensively weakened
the interaction of DN-CSNAP with the CSN. The most pronounced effect was observed for the F44A-F51A double mutant, which entirely abolished the DN-
CSNAP/CSN interaction.F/D region alone is sufficient for CSNAP/CSN assembly. In the
nucleus, DDB2 exhibited a clearly slower recovery compared
to that of Cer-CSN3 and Cer-CSNAP, reflecting some degreeCof transient immobilization. Taken together, the similar mobility
kinetics of CSNAP and CSN3 strongly suggest that CSNAP is
an integral component of the holo-CSN complex.ell Reports 13, 585–598, October 20, 2015 ª2015 The Authors 591
Figure 4. Live Cellular Analyses Indicate that CSNAP Is an Integral
CSN Subunit
(A) HeLa cells were fractionated into cytoplasmic, nuclear soluble, and chro-
matin-associated fractions, with or without prior exposure to UV light.
Fractions were separated on tricine-SDS gels, and blots were probed with
anti-CSN1, CSN8 and CSNAP antibodies. As controls, anti-tubulin and anti-
histone 3 antibodies were used. Like CSN subunits, CSNAP, but not MYEOV2-
L (My2-L), is recruited to the nucleoplasmic and chromatin fractions following
DNA damage induction.
(B) FRAP curves of full-length CSNAP-Cer, as well as its deletion mutants, DN-
CSNAP-Cer and CSNAP-DC-Cer, were compared to those obtained for free
592 Cell Reports 13, 585–598, October 20, 2015 ª2015 The AuthorsCSNAP Interacts with CSN3, CSN5, and CSN6
To determine which of the CSN subunits binds CSNAP, we per-
formed chemical cross-linking reactions using BS3, a homobi-
functional amine-reactive compound that reacts predominantly
with the primary amines in lysine side-chains, and the N termini
of polypeptide chains (Kalkhof and Sinz, 2008). We then moni-
tored the change in the protein’s band pattern by running
denaturing gel electrophoresis (SDS-PAGE) before and after
cross-linking. Immunoblotting with anti-CSNAP and various
anti-CSN antibodies revealed the appearance of similarly sized,
higher-molecular-mass species for CSNAP and CSN3, CSN5,
and CSN6 (Figure 5A). The CSNAP-CSN3, CSNAP-CSN5, and
CSNAP-CSN6 bands were sensitive to the presence of a dena-
turing agent: when SDS was added and the sample was boiled
prior to the cross-linking reaction, the cross-linked species
were eliminated, implying the specificity of the interaction (Fig-
ure 5A). In contrast, cross-links with CSNAP were not identified
for CSN1, CSN2, and CSN8.
Despite numerous attempts, we were unable to map the spe-
cific sites of association between CSNAP and CSN3, CSN5,
and CSN6 using proteomic MS analysis. This is likely due to
CSNAP’s relatively small size and the few peptides it produces,
reducing the odds of identifying explicit CSNAP cross-linked
species within the complex mixture of CSN peptides. Nonethe-
less, when we examined the recently solved crystal structure
of the recombinant CSN complex (Lingaraju et al., 2014), the
only region in which CSN3, CSN5, and CSN6 are in proximity,
and their surfaces not obscured by the other subunits, is near
the C-terminal helices of CSN3 and CSN6, and the loop 284-
295 of CSN5, which connects its two C-terminal helices (Fig-
ure 5B). Near this region, we noted a highly positive patch on
the CSN3 surface that contains several exposed lysine residues
capable of forming a cross-link with CSNAP. Lysine residues of
CSN5 and CSN6, which could act as additional cross-link tar-
gets, are located near the CSN3 positive patch (Figure 5C).
This patch, which corresponds to the PCI domain of CSN3, in-
cludes several hydrophobic pockets, which are preferred
phenylalanine binding sites as determined by ANCHORSmap
(Ben-Shimon and Eisenstein, 2010). From the crosslinking re-
sults, and the structural features of CSNAP and the CSN sub-
units, we suggest that the positive patch of CSN3 binds the
CSNAP F/D-rich motif by forming ionic interactions with the
negative charges and hydrophobic interactions with CSNAP
Phe44, Phe51, and perhaps also Phe47. Other parts of CSNAP
bind near the helical bundle region, thus tethering the
MPN dimer of CSN5 and CSN6 to the PCI proteins, through
CSN3.
CSNAP and DSS1 Share Sequential and Structural
Properties
At this point, we referred to the related 19S lid complex, which
shares one-to-one subunit correspondence with the CSN,Cer and fluorescently labeled CSN3 and DDB2. Each plot constitutes an
average of at least 40 cells, normalized to pre-bleach intensity. To better
display the mobility differences between the measured cell lines, the regions
within the dashed squares were enlarged (insets).
Figure 5. CSNAP Interacts with CSN3, CSN5, and CSN6
(A) FLAG-tagged CSN was purified from HEK293T cells and cross-linked with BS3. As a control for specific CSNAP association, FLAG-CSN was denatured with
1% SDS and boiled for 5 min, prior to addition of the cross-linker. After quenching the reaction, the complex was precipitated with acetone, followed by western
blot analysis with antibodies against CSNAP and CSN subunits. The data revealed that CSNAP forms a cross-link with CSN3, CSN5, and CSN6.
(B) An overall view of the CSN crystal structure, showing the surfaces of the eight subunits (Lingaraju et al., 2014). The black frame delineates the region where
CSN3, CSN5, andCSN6 are found in close proximity. This region, enlarged in (C) and (D), includes theC-terminal helices of CSN3 andCSN6 and the loop 284–295
of CSN5, which connects its two C-terminal helices.
(C) The electrostatic potential on the surfaces of CSN3, CSN5, and CSN6: blue for positive, red for negative, and white for neutral. The highly positive patch of
CSN3 is seen at the top left. Exposed lysine residues that may be involved in cross-linking are indicated: K237, K243, K254, and K312 of CSN3; K191, K194, and
K299 of CSN5; and K306 of CSN6. The positive patch includes several hydrophobic pockets, which are preferred anchoring sites of Phe residues, as predicted by
ANCHORSmap. Anchored Phe side chains with DG < 4 kcal/mol are shown in yellow.
(D) Superposition of the PCI domain of PCID2 (brown) in the complex with DSS1 (Ellisdon et al., 2012), onto the PCI domain of CSN3 (gray). The F/D-rich region of
DSS1 (golden coil) binds to the front face of PCID2, which corresponds to the positive patch of CSN3.except for DSS1, which is missing a counterpart. We noticed,
however, that CSNAP and DSS1 not only share sequential sim-
ilarity (Figure S4A) but also belong to the same intrinsically un-Cstructured protein family (Figure S4B). Thus, CSNAP could
potentially be the subunit homologous to DSS1 and, as such,
may occupy a similar position within the CSN architecture.ell Reports 13, 585–598, October 20, 2015 ª2015 The Authors 593
The molecular architecture of the 26S holocomplex was
recently determined using cryo-electron microscopy single-par-
ticle analyses; however, the position of DSS1/Sem1 within the lid
was not resolved due to its small size (Beck et al., 2012; Lander
et al., 2012; Lasker et al., 2012). Nevertheless, cross-linking anal-
ysis and biochemical characterization indicated that DSS1/
Sem1 forms a subcomplex with RPN3 and RPN7, enforcing their
joint incorporation into the lid (Fukunaga et al., 2010; Sharon
et al., 2006; Tomko and Hochstrasser, 2014). Comparative
cryo-electron microscopy maps and cross-linking restraints po-
sition DSS1/Sem1 in the cleft between the PCI domains of Rpn7
and Rpn3, while its central part lies near the N-terminal region of
Rpn3. This mode of binding, near the 19S lid helical bundle, fas-
tens the lid together (Bohn et al., 2013; Kao et al., 2012; Tomko
and Hochstrasser, 2014). Based on the cross-linking results, it
seems that CSNAP occupies an analogous binding mode in
which it tethers the MPN subunits CSN5 and CSN6 to the PCI
CSN3 subunit at the helical bundle region. More evidence of
this binding mode is provided by superpositioning the PCI sub-
unit of PCID2 in the PCID2/DSS1 complex (Ellisdon et al.,
2012) onto the PCI domain of CSN3, showing that the DSS1
binding surface of PCID2 corresponds to the CSN3-positive
patch, proposed here to be the CSNAP binding surface (Fig-
ure 5D). Small differences in the actual binding modes support
the observation that CSNAP andDSS1/Sem1 are intrinsically un-
structured proteins; therefore, their interaction partners co-
determine their structure, as previously shown for DSS1 (Ellisdon
et al., 2012; Yang et al., 2002). Overall, it suggests that like DSS1/
Sem1, CSNAP connects subunits within the complex.
CSNAP-Depleted Cells Display a Distinct Phenotype
To test whether CSNAP confers functional significance, HAP-1
cell lines lacking CSNAP (DCSNAP cells) were generated using
the CRISPR system. Initially, pull-down assays using an anti-
CSN3 antibody confirmed that CSNAP is absent from the CSN
complex in the DCSNAP cell line (Figure 6A). Next, cell extracts
of wild-type and DCSNAP cells were passed through a column
containing CSNAP-conjugated beads. After washing, beads
were boiled in SDS-PAGE sample buffer, and the bound proteins
analyzed by western blots. We found that only CSN from the
DCSNAP cells was able to bind the CSNAP-column, whereas
that from the wild-type cells did not bind (Figure 6B). This result
not only validated the lack of CSNAP in the engineered cells, it
also confirmed the stoichiometric CSN/CSNAP association in
wild-type cells.
We then examined whether the enzymatic activity of the
DCSNAP andwild-type CSN complexes differ. No significant dif-
ference in the deneddylation capacity was observed between
wild-type and DCSNAP cells (Figure 6C). This observation is in
accordance with a previous study that compared the rate of de-
neddylation of endogenous CSN prepared from HEK293 cells
with that of recombinant CSN expressed in insect cells (Ember-
ley et al., 2012). Although the recombinant CSN might contain
the insect CSNAP protein, it is unlikely to be stoichiometric,
due to its very high overexpression levels. Thus, CSNAP might
not have a significant effect on the enzymatic activity of the CSN.
Next, we examined whether the lack of CSNAP gives rise to a
detectable cellular phenotype. To this end, we performed cell594 Cell Reports 13, 585–598, October 20, 2015 ª2015 The Authorsproliferation assays and compared the growth potential of
wild-type and DCSNAP HAP-1 cells. Our data (Figure 6D)
show that there is a clear reduction in cell proliferation in the
DCSNAP clone compared to the wild-type cells. Furthermore,
microscopy analysis of both cell types demonstrated that
DCSNAP cells display a flattened and enlarged cell phenotype
compared to wild-type cells (Figures 6E–6G). These results indi-
cate that the lack of CSNAP generates a distinct phenotype, indi-
cating the functional significance of this small subunit. Neverthe-
less, further research is required in order to determine the
specific mechanistic function of CSNAP.
DISCUSSION
Here, we show that CSNAP, a 6.2-kDa protein, is a stoichio-
metric subunit of the CSN complex. The protein’s second, longer
isoform, MYEOV2-L (27.7 kDa), which contains the entire
sequence of CSNAP except for the C-terminal amino acid, is
not, however, part of the complex. Moreover, we demonstrate
that the C-terminal F/D-rich region of CSNAP is necessary and
sufficient for its incorporation into the CSN and, in particular,
conserved Phe44 and Phe51 take part in this interaction. Our
data also demonstrate that CSNAP binds to CSN3, CSN5, and
CSN6, possibly linking the MPN and PCI substructures. Finally,
we found that the absence of CSNAP had a marked effect on
the cellular morphology and proliferation rate. Although this
result implies biological relevance, further investigation is re-
quired to determine the specific functional role of CSNAP. It is
tempting to suggest that it contributes to the complex stability
or flexibility, enabling the CSN to associate and dissociate
from the variable CRL complexes.
CSNAP was first identified as an overexpressed gene in ARH-
77 cells (Tang et al., 2003), which were considered to be cultures
of human myeloma cells, giving the protein its original name,
MYEOV2 (myeloma-overexpressed gene 2). Notably, however,
these cells were shown to be a false malignant hematopoietic
cell line, essentially representing Epstein-Barr virus (EBV)-trans-
formed B lymphoblastoid cells (Drexler et al., 1999), a fact that
supports our suggestion to rename the protein. Still, this study
stimulated us to examine whether overexpression of CSNAP in
ARH-77 cells is coordinated with the other CSN subunits, as ex-
pected of constituents of the same protein complex (Eisen et al.,
1998; Jansen et al., 2002). Interestingly, analysis of microarray
data using the GeneVestigator database revealed not only that
the expression levels of the entire CSN complex, including
CSNAP, are highly comparable in ARH-77 and various other
cell lines (Figure S5A) but also that similar expression coherence
is obtained across different tissues and organs (Figure S5B).
Likewise, when we examined the expression patterns in a range
of cancers (e.g., colon, leukemia, and lung) reported to induce
overexpression of CSN5 and/or CSN6 (Adler et al., 2008; Chen
et al., 2014), the entire CSN complex, including CSNAP, dis-
played similar expression levels (Figure S5C). Together, these re-
sults indicate that all CSN-encoding genes, including CSNAP,
show similar expression patterns, as expected from subunits
of the same protein complex (Jansen et al., 2002).
The first documentation concerning the existence of CSNAP
at the protein level came from a global proteomic analysis
Figure 6. CSNAP-Depleted Cells Display a
Distinctive Phenotype
(A) The CSN complex was FLAG-affinity purified
from wild-type (WT) or from CSNAP knockout
cells (DCSNAP), stably expressing FLAG-CSN1.
CSNAP was detected by western blot using an
anti-CSNAP antibody only in the complex isolated
from WT, but not DCSNAP, cells.
(B) The WT CSN complex is saturated with
endogenous CSNAP. Lysates from WT and
DCSNAP cells stably expressing FLAG-CSN1
were passed through Aminolink beads coupled to
a CSNAP-peptide. Only the CSN complex from
the DCSNAP, but not from the WT lysate, could
bind to the beads.
(C) WT and DCSNAP cells exhibit a similar rate of
deneddylation. Deneddylation was monitored at
different time points. A representative deneddy-
lation assay (top panel) and a plot demonstrating
the average activity of three independent experi-
ments (bottom panel). As a negative control (NC),
lysates were denatured (boiled) prior to the assay.
Bars represent SE.
(D) DCSNAP cells exhibit lower proliferation rates,
as measured using the resazurin proliferation
assay. Plot represents the average proliferation
rate of three independent experiments. Measure-
ments were subjected to t test analysis; *p < 0.05.
(E) DCSNAP cells are flatter and larger than WT
cells. Cells plated at a low density were imaged
using a confocal microscope. Partially dispersed
cells displaying distinct cellular borders were used
to measure the cellular area of WT (n = 277) and
DCSNAP cells (n = 263). Bars represent SE.
Measurements were subjected to t test analysis;
***p < 1015.
(F) Size distribution of WT and DCSNAP cell areas,
represented as percent of the total population.
(G) A representative confocal image of WT and
DCSNAP cells. Bar represents 20 mm.aimed at identifying deubiquitinating enzyme-associated pro-
teins (Sowa et al., 2009). The study indicated that CSNAP is
pulled down, together with CSN6. Similarly, a methodological
study focused on the effectiveness of multidimensional separa-
tion techniques for MS analysis indicated that MYEOV2 is
repeatedly identified in FLAG-CSN5 purifications (Dunham
et al., 2011). A later study, focusing on the subnuclear localiza-
tion of the ribosomal L11 protein, indicated that overexpression
of a FLAG-tagged construct containing the N-terminal region
of MYEOV2-L, comprising the F/D-rich motif, is co-immunopre-
cipitated with CSN5, Cul1, and Cul3 (Ebina et al., 2013).
In contrast, a construct containing the long, MYEOV2-L C-termi-
nal tail could not interact with the CSN complex. Moreover, a
genetic screen searching for A. thaliana mutants that display
resistance to the auxin inhibitor p-chlorophenoxyisobutyricCell Reports 13, 585–598acid identified the small acidic protein 1
(SMAP1) (Rahman et al., 2006), the plant
ortholog of CSNAP. A subsequent study
indicated that SMAP1 physically binds
the CSN complex via the F/D-rich region(Nakasone et al., 2012). Taken together, these results support
our view that CSNAP is an integral component of the CSN
complex.
The CSN complex is conserved throughout eukaryote evolu-
tion, from fungi to humans (Schwechheimer, 2004; Wei et al.,
2008). Therefore, it would be expected that as a CSN compo-
nent, CSNAPwould be similarly conserved. To examine this pos-
sibility, we performed bioinformatics searches, the results of
which indicated that CSNAP is highly conserved in all chordates
and also displays a high degree of similarity in lower eukaryotes
(Figure S6). In plants, conservation is mainly maintained in the
C-terminal F/D-rich region, the domain essential for CSN inte-
gration. We could not, however, identify a yeast ortholog of
CSNAP, perhaps because the protein diverged to such an extent
that it is difficult to identify it by homology database searches;, October 20, 2015 ª2015 The Authors 595
Figure 7. DSS1 andCSNAPAre Intrinsically Disordered Proteins that
Share Sequential and Functional Homology
Schematic illustration of the one-to-one sequence homology between the
CSN and 19S proteasome lid complexes. CSNAP may represent the missing
homologous partner of DSS1. The percentage of sequence identity between
the subunits is labeled for each pair.rather, experimental approaches are required. More conserva-
tional support for the CSN/CSNAP link comes from the fact
that CSN7b, CSN8, and CSNAP are all located in the same chro-
mosomal region (2q37) and that they are found together in syn-
tenic regions in all mammalian species (e.g., mouse, rat, horse,
and pig) whose DNA sequences are available so far. In marsu-
pials, there is no CSN7b gene; however, CSN8 and CSNAP are
co-localized on the same chromosome. The shared synteny in
mammals may reflect selection due to a functional relationship
(Moreno-Hagelsieb et al., 2001), strengthening the link between
CSNAP and the CSN.
Unlike CSNAP, there is very little transcriptional evidence that
MYEOV2-L is expressed in humans; thus far, no such evidence
has been found in other species at all (Figure S7). The lack of
conservation in all non-primates makes it highly unlikely that it
exists in those species. Even in primates, where the exon se-
quences are mostly present, the splice junctions, particularly in
the fourth exon, are defective in all species except chimp and hu-
man. Therefore, this isoform is most likely human or human/
chimp specific and unlikely to play a role in a complex as highly
conserved as the CSN.
A striking one-to-one correspondence exists between the
CSN subunits, and those of the 19S lid subcomplex of the 26S
proteasome, suggesting that they diversified from a common
ancestor (Glickman et al., 1998; Seeger et al., 1998). The two
signature structural motifs entail six subunits with a PCI and
twowith anMPNdomain, all foundwithin each of the complexes.
The lid subunit DSS1 (Sem1 in budding yeast) is the only excep-
tion: DSS1 does not contain a PCI or MPN fold; moreover, it is
missing a counterpart within the CSN. Considering that (1) like
CSNAP, DSS1 links 19S proteasome lid subunits (Paraskevo-
poulos et al., 2014; Sone et al., 2004; Tomko and Hochstrasser,
2014), though an intact complex can be formed in its absence
(Paraskevopoulos et al., 2014); (2) CSNAP andDSS1 are remark-
ably small proteins that share 18% sequential identity and 26%
similarity, including a C-terminal region enriched with aromatic
and acidic residues (Figure S4A); and (3) both proteins belong
to the intrinsically unstructured protein family (Figure S4B), we
suggest that DSS1 and CSNAP are paralogous subunits, filling
the missing gap of homology between the 19S lid and CSN com-
plexes (Figure 7).596 Cell Reports 13, 585–598, October 20, 2015 ª2015 The AuthorsTwo decades have passed since the discovery of the CSN
complex (Chamovitz et al., 1996; Wei et al., 1994); thus, a key
question arises: How has the CSNAP/CSN association escaped
previous detection? The answer probably lies within the
sequence of CSNAP. First, the low molecular weight of the pro-
tein is likely to cause its rapid migration outside polyacrylamide
electrophoresis gels, preventing its detection. Second, even if
CSNAP is retained within the gel, the fact that it contains only
two basic amino acids, i.e., two lysine residues, gives rise to
poor Coomassie dye staining (Syrovy´ and Hodny´, 1991). Finally,
proteomic identification of CSNAP might also be challenging,
considering that tryptic peptides are typically analyzed (Mann
et al., 2001). This procedure generates only two CSNAP pep-
tides, and their long length, which is in the upper mass scale
for typical analysis, also challenges identification. Hence, the
methodology we described herein, which couples bottom-up
and top-down MS analysis, set the stage for the discovery of
CSNAP and paves the way toward identification of additional
small proteins that act as integral subunits of large protein
complexes.
EXPERIMENTAL PROCEDURES
Purification of the CSN Complex
CSN was isolated from human erythrocytes according to a previously pub-
lished protocol (Hetfeld et al., 2005). FLAG purification of CSN is described
in the Supplemental Experimental Procedures.
Generation of a Polyclonal Antibody against CSNAP
The full-length CSNAP peptide was conjugated to KLH (Sigma Aldrich) using
the BS3 crosslinker (Pierce, Thermo Scientific) and used for immunization in
rabbits. After three boosts, serum was obtained, and anti-CSNAP antibodies
were affinity-purified on CSNAP peptide coupled to Aminolink beads (Pierce,
Thermo Scientific) and stored in 50% glycerol at 20C. Specificity was vali-
dated in comparison to pre-immune serum against synthetic CSNAP and
cell lysates.
Subcellular Fractionation
HeLa cells were fractionated to cytoplasmic, nuclear-soluble, and chromatin-
bound fractions, with or without exposure to 20 J/cm2UV-C, as described pre-
viously (F€uzesi-Levi et al., 2014). UV-C-exposed samples were collected
10 min after induction of UV damage.
Activity Assay
Deneddylation activity of HAP1 cell lines was measured as in F€uzesi-Levi et al.
(2014). At each time point, deneddylation activity was calculated as the
measured intensity of the deneddylated band divided by the total intensities
of the neddylated and deneddylated bands and normalized to maximal activity
(10 min). Average activity levels and SEs were calculated for each time point
from three independent experiments.
LC-MS Approach
The monolithic-LC-MS approach was performed as previously described (Ro-
zen et al., 2013).
Native MS Analysis
Nanoelectrospray ionization MS and MS/MS experiments were performed on
a Synapt G2 instrument (Waters), as described previously (Kirshenbaum et al.,
2010).
Confocal Fluorescence Microscopy
Confocal fluorescence imaging and FRAP measurements were performed as
previously described (F€uzesi-Levi et al., 2014).
SUPPLEMENTAL INFORMATION
Supplemental information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.09.021.
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